Australia - engelsk - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the vardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections; trometamol hydrochloride - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium calcium edetate; sodium hydroxide; trometamol hydrochloride; water for injections; trometamol - optiray is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include cerebral, coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretory urography.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.